Babyscripts exists to solve the problems generated from the shortage of obstetrical providers in the US, as well as systemic and structural failures presenting barriers to care for low-income and minority women. Babyscripts offers virtual maternity care experiences that address an outdated model for pregnancy care that has not moved the needle on maternal outcomes; an inability to address social determinants of health including financial insecurity, intimate partner violence, and food scarcity; and the increasing demand for virtual solutions following Covid-19. Seven million birthing people in the US live in an area with limited or no access to maternity care. These “maternity care deserts” encompass urban and rural areas— Babyscripts’ home city of Washington DC is a maternity care desert, with about 50% of the birthing population living in a quadrant of the city with no maternity wards. These women, often struggling economically, have to travel across the city using multiple forms of transportation to receive care or deliver a baby. Similarly, across the country, community hospitals are closing or closing their OB units, making it harder to access quality care for delivery and forcing birthing parents to travel farther for appointments. Fifty-percent of rural counties do not have practicing OB/GYNs and more are lacking a midwife, widely used in rural/low income communities as an access point for care. With virtual maternity care, birthing patients are able to access education, monitor biometric data, and stay connected to their provider regardless of risk, race, income, or geography.
Babyscripts’ Virtual Maternity Care solution consists of a three-tiered approach. The first tier is a digital education layer delivered via a mobile app, with daily gestational-age and practice-specific, customizable content extending through one year postpartum. By giving the patient 24/7 access to digital resources approved by their care provider, the app cuts down on misinformation found through internet sources, and also eliminates the need for clunky and expensive paper resources. The second tier enables remote management of pregnant patients dependent on risk; including low-risk, hypertension, postpartum hypertension, gestational diabetes, mental health, and social determinants of health, through connected or manual medical devices. Patient-generated biometric data is communicated directly from the Babyscripts app into the patient EHR, allowing providers to identify elevated risks remotely. Through a unique trigger system, abnormalities and risk factors alert providers to patient risk immediately, enabling real-time interventions and risk management. Remote monitoring solutions help to resolve barriers of distance for mothers who are living in maternity care deserts or otherwise struggling with barriers to access. The third tier brings the insurer into the equation in a collaboration between care team and payer, solving some of the structural issues of care coordination and access to care, improving outcomes while reducing cost. Payors sponsor the cost of Babyscripts for their members at participating hospitals to identify pregnancy earlier, detect risk faster, connect members to local resources, and reduce poor outcomes like C-sections and preterm birth, among other things.
Our primary competitive threats fall almost entirely into two categories: internal solutions that are built in-house and/or sit on top of current EMRs and prenatal patient engagement apps. Babyscripts is the only clinically-validated, obstetrics-specific virtual care platform. The solution has been the focus of several research studies and pilot programs; and instrumental in many life-saving interventions. These studies and outcomes have shown significant cost savings associated with using Babyscripts to manage pregnant patients. The efficiencies of Babyscripts have enabled pregnant mothers at every risk level to attend fewer than the number of routine appointments recommended by the IOM study from 1985, allowing physicians to more effectively allocate care and free up appointment slots. Babyscripts differentiates itself from consumer maternity apps with 1) educational information that aligns with a provider’s care plan, and 2) internet-enabled medical devices that directly triage information like high blood pressure back to the physician automatically in their desired workflow. Babyscripts differs from payer sponsored apps in its 1) connection to the provider, and 2) internet-enabled monitoring devices to detect abnormal trends and then triage those data points directly to the provider. Babyscripts differs from non-obstetric based clinical apps as the only clinical tool that is singularly focused on solving obstetrical problems. As a consequence of this targeted approach, Babyscripts has one of the largest databases on weight, blood pressure, and symptomatic information, which can be leveraged to answer some of the most meaningful questions in pregnancy.
Babyscripts (BRx) has been the focus of several research studies and pilot programs, and instrumental in many life-saving interventions, frequently related to early identification of blood pressure related complications such as preeclampsia and postpartum hypertension. At Cone Health, the use of BRx blood pressure (BP) monitoring resulted in a 59.4% reduced risk of anemia and reduced frequency of C-sections: 16% of pregnancies required C-sections (vs. 21.1% not enrolled on BRx). Patients with anemia enrolled on BRx were 27.8% less likely to exceed their expected MS-DRG than those not enrolled. Patients enrolled on BRx with BP monitoring were 22.4% less likely to experience preterm birth, and there was a 22.2% reduction in the time it takes to identify preeclampsia/gestational hypertension. In the Medicaid population, BRx improved HEDIS measures: at Advocate Aurora Health, use of BRx reduced no show rate by 67%, at Atrium Health by 50%. BRx has also been shown to improve adherence to postpartum visits. At Wellspan Health, the baseline postpartum visit attendance is 75%. With BRx, 100% of patients have been scheduled for a postpartum visit, with 86% rate of attendance. BRx has been proven to prevent excessive weight gain during pregnancy. In a study out of Northwestern, BRx monitoring of low risk moms resulted in a 55% reduction in excessive weight gain in overweight patients, and a 41% reduction in postpartum weight retention.
Babyscripts has the most sophisticated obstetrics-specific RPM solution on the market, and we are constantly refining our solution and leveraging strategic partnerships to provide cutting-edge comprehensive care. BRx recently formed an R&D collaboration with Roche Diagnostics, and is piloting a maternal mental health solution with physician partners at GW-MFA.